U.S. FDA approves Medtronic brain device

WASHINGTON Feb 19 (Reuters) - U.S. health officials approved Medtronic Inc's (MDT.N) deep brain stimulator to help treat patients with severe obsessive-compulsive disorder, or OCD.

The device, Reclaim DBS Therapy, was cleared on Thursday under the agency's human device exemption policy, the FDA said. Under such approvals, Medtronic had to show the device was safe and offered "probable benefit." (Reporting by Susan Heavey; Editing by Lisa Von Ahn)